Biohaven (BHVN) Change in Account Payables (2021 - 2026)
Biohaven's (BHVN) quarterly Change in Account Payables came in at -$1.2 million in Q1 2026, down 1441.76% year-on-year from $91000.0 in Q1 2025, and up 79.12% quarter-over-quarter from -$5.8 million in Q4 2025.
Biohaven (BHVN) Change in Account Payables (2021 - 2026) Analysis & Trends
Biohaven has disclosed Change in Account Payables across 6 years of filings, most recently posting -$1.2 million for Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$1.2 million, down 1441.76% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.7 million (up 57.85% YoY), and the FY2025 annual result was -$6.4 million, down 999.44% from the prior year.
- Change in Account Payables came in at -$1.2 million for Q1 2026 at Biohaven, up from -$5.8 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $19.1 million in Q1 2024 to a low of -$19.1 million in Q2 2024.
- The 5-year median for Change in Account Payables is -$325000.0 (2022), against an average of $229705.9.
- Across the five-year window, Change in Account Payables jumped 408.02% in 2024 and slumped 1441.76% in 2026, its largest moves.
- Biohaven's Change in Account Payables stood at $6.0 million in 2022, then climbed by 1.51% to $6.1 million in 2023, then sank by 128.29% to -$1.7 million in 2024, then plunged by 240.99% to -$5.8 million in 2025, then jumped by 79.12% to -$1.2 million in 2026.
- The last three Change in Account Payables figures came in at -$1.2 million (Q1 2026), -$5.8 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -9.42 Mn |
| 10 | Biohaven | 1.62 Bn | 1.27 Bn | - | -1.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.22 Mn |
| Mar 31, 2026 | -1.22 Mn |
| Dec 31, 2025 | -5.85 Mn |
| Dec 31, 2025 | -5.85 Mn |
| Sep 30, 2025 | -2.14 Mn |
| Sep 30, 2025 | -2.14 Mn |
| Jun 30, 2025 | 1.51 Mn |
| Jun 30, 2025 | 1.51 Mn |
| Mar 31, 2025 | 91,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Dec 31, 2024 | -1.72 Mn |
| Dec 31, 2024 | -1.72 Mn |
| Sep 30, 2024 | 2.49 Mn |
| Sep 30, 2024 | 2.49 Mn |
| Jun 30, 2024 | -19.13 Mn |
| Jun 30, 2024 | -19.13 Mn |
| Mar 31, 2024 | 19.07 Mn |
| Mar 31, 2024 | 19.07 Mn |
| Dec 31, 2023 | 6.06 Mn |
| Dec 31, 2023 | 6.06 Mn |